سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - anagrelide (as hcl) - capsule - 0.61mg - anagrelide (as hcl) 0.61mg

إسرائيل - الإنجليزية - Ministry of Health

rafa laboratories ltd - anagrelide as hydrochloride - capsules - anagrelide as hydrochloride 0.5 mg - anagrelide - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

shire pharmaceutical contracts limited - anagrelide - thrombocythemia, essential - antineoplastic agents - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

shire pharmaceuticals ltd - anagrelide hydrochloride - capsule - 500microgram

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - anagrelide hydrochloride - capsule - 500microgram

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

mylan pharmaceuticals limited - anagrelide hydrochloride - thrombocythemia, essential - antineoplastic agents - anagrelide is indicated for the reduction of elevated platelet counts in at risk essential thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.an at-risk patientan at-risk essential thrombocythaemia patient is defined by one or more of the following features:>60 years of age ora platelet count >1,000 x 10⁹/l ora history of thrombo-haemorrhagic events. 

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

kent pharmaceuticals limited - anagrelide - capsules hard - 0.5 milligram - anagrelide

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - anagrelide - capsule, hard - 0.5 milligram(s) - other antineoplastic agents; anagrelide

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - anagrelide - capsule, hard - other antineoplastic agents; anagrelide

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - anagrelide hydrochloride 0.5 mg - capsules - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.